4//SEC Filing
MOMENTA PHARMACEUTICALS INC 4
Accession 0001179110-17-002062
CIK 0001235010operating
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:52 PM ET
Size
7.8 KB
Accession
0001179110-17-002062
Insider Transaction Report
Form 4
Ottmer Matthew P.
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-02-07+48,000→ 48,000 totalExercise: $18.85Exp: 2027-02-07→ Common Stock (48,000 underlying) - Award
Restricted Stock Units
2017-02-07+24,000→ 24,000 total→ Common Stock (24,000 underlying)
Footnotes (3)
- [F1]Subject to certain criteria, the stock option will vest and become exercisable with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
- [F2]Each restricted stock unit represents a contingent right to receive one share of MNTA common stock.
- [F3]Subject to certain criteria, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
Documents
Issuer
MOMENTA PHARMACEUTICALS INC
CIK 0001235010
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001235010
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 4:52 PM ET
- Size
- 7.8 KB